On June 6-9 2018 prof. Hans Bluyssen, prof. Joanna Wesoły, Aleksandra Antończyk and Anna Piaszyk-Borychowska participated in TOLL 2018 Editing Innate Immunity conference in Porto, Portugal. Continue reading “TOLL 2018 Editing Innate Immunity – conference”
News
Postdoc position
The Department of Human Molecular Genetics, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University in Poznan, headed by Prof. dr hab. Hans A.R. Bluyssen, invites applications for a postdoctoral position.
The position is currently available and funded by the National Science Centre within OPUS grant UMO-2016/23/B/NZ2/00623, entitled: “Characterization of a novel intracellular amplifier circuit that controls long-term responsiveness to type I and type II IFNs.”
The project combines state of the art technologies with a highly ambitious and competitive research environment.
PhD procedure openings
On 10th May 2018 three our PhD candidates, Anna Piaszyk-Borychowska (DHMG), Martyna Plens-Gałąska (DHMG) and Natalia Pstrąg opend PhD procedures.
Scholarship by the French Government for Natalia Pstrąg
On April 12th Natalia Pstrąg, our PhD candidate, was awarded the BGF “codirection” scholarship by the French Government. Thanks to this opportunity, she will be performing part of her PhD project in collaboration with the “Computational Epi- Genetics of Cancer” department, led by Valentina Boeva in the Cochin Institute in Paris.
“23rd International Conference on Cancer Research and Pharmacology” in Edinburgh
From 26th to 27th March PhD candidate Weronika Majer and PhD Katarzyna Kluzek , members of the Laboratory of High Throughput Technologies, attended the “23rd International Conference on Cancer Research and Pharmacology” in Edinburgh. Our colleagues presented poster titled “Novel approach in monitoring of clear cell renal cell carcinoma (ccRCC) using molecular biomarkers” that won The Award for Best Poster. During Conference speakers presented talks about recent research and developments in cancer diagnosis, cancer therapy and pharmacology.
Transmembrane proteins in Health and Disease conference
From 11 to 15 April three members of the Laboratory of High Throughput Technologies, Dr Arkadiusz Kajdasz and PhD candidates Natalia Pstrąg and Daria Niewiadomska, attended the 61st annual CSMB conference entitled “Transmembrane proteins in Health and Disease” in Banff, Canada. Continue reading “Transmembrane proteins in Health and Disease conference”
Kaja Kostyrko seminar lecture
Last Friday former member of our department, Kaja Kostyrko (Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, USA) had very interesting lecture during the Institute seminar entitled “Identification of novel synthetic lethal vulnerabilities in KRAS-driven lung cancer”. Kaja thank you for your nice presentation!
Professorship title for Joanna Wesoły
We are happy to inform you that the head of LHTT, Joanna Wesoły is now officially a professor. On 23/09/2017 she received professorship from the President of Poland.
Cattle-based agriculture in the Early and Middle Neolithic in the Polish lowlands – genetic and zooarchaeological characterization.
We are happy to inform you that the LHTT in cooperation with prof. dr hab. Arkadiusz Marciniak (Faculty of History, AMU) will take part in the grant from NCN entitled “Cattle-based agriculture in the Early and Middle Neolithic in the Polish lowlands – genetic and zooarchaeological characterization”.
Environmental Factors in clear cell Renal Cell Carcinoma – Contribution of Ionizing Radiation to the development and progression of ccRCC – Grant
We are happy to inform you that the head of LHTT, Joanna Wesoły has received a research grant from NCN entitled “Environmental Factors in clear cell Renal Cell Carcinoma – Contribution of Ionizing Radiation to the development and progression of ccRCC“.
Preludium Grant
We are happy to inform you that Hanna Nowicka has received Preludium Grant from NCN entitled “The cooperation/role of unphosphorylated and phosphorylated ISGF3 components in the regulation of ISG expression and viral protection” (“Zrozumienie współdziałania/roli nieufosforylowanych i ufosforylowanych form komponentów wchodzących w skład kompleksu ISGF3 w regulacji ekspresji ISGs i obrony przed infekcjami wirusowymi”).
Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease
We are glad to inform you, that Professor Hans Bluyssen, the head of our Department, has received a research grant form NCN: Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease.